VA
NVO

VestGen Advisors’s Novo Nordisk NVO Stock Holding History

VestGen Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$554K Sell
11,565
-288
-2% -$12.4K 0.02% 638
2026
Q1 		$557K Buy
11,853
+7,114
+150% +$337K 0.01% 630
2025
Q4 		$241K Buy
4,739
+141
+3% +$7.21K 0.01% 665
2025
Q3 		$255K Sell
4,598
-3,121
-40% -$183K 0.01% 629
2025
Q2 		$533K Buy
7,719
+497
+7% +$33.8K 0.02% 413
2025
Q1 		$501K Buy
+7,222
New +$596K 0.02% 385

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

VestGen Advisors's NVO Position: Q2 2026 in Review

VestGen Advisors reduced its Novo Nordisk (NVO) stake by 2.4% in Q2 2026, selling an estimated $12.4K and leaving 11,565 shares worth $554K. The position accounts for 0.02% of the portfolio, ranked #638.

VestGen Advisors first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $557K in Q1 2026. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • VestGen Advisors held 11,565 shares of Novo Nordisk worth $554K as of Q2 2026.
  • VestGen Advisors sold 288 Novo Nordisk shares in Q2 2026, an estimated $12.4K.
  • Novo Nordisk made up 0.02% of VestGen Advisors's portfolio in Q2 2026, its #638 holding.
  • VestGen Advisors first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
  • VestGen Advisors's Novo Nordisk position peaked at $557K in Q1 2026.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.